机构：[1]Fourth Hospital of Hebei Medical University, Department Radiation Oncology, Sijiazhuang- Hebei, China河北医科大学第四医院[2]Fourth Hospital of Hebei Medical University, Department of Radiation Oncology, Shijiazhuang, China河北医科大学第四医院胸部放疗三病区临床科室[3]Fourth Hospital of Hebei Medical University, Department of RadiationOncology, Shijiazhuang, China河北医科大学第四医院胸部放疗三病区临床科室
第一作者机构：[1]Fourth Hospital of Hebei Medical University, Department Radiation Oncology, Sijiazhuang- Hebei, China
推荐引用方式(GB/T 7714)：
Zhu S.,Shuguang L.,Youmei L.,et al.The value of postoperative adjuvant therapy for pT2-3 esophageal cancer treated by radical resection[J].RADIOTHERAPY AND ONCOLOGY.2017,123:S358-S358.doi:10.1016/S0167-8140(17)31122-2.
APA：
Zhu, S.,Shuguang, L.,Youmei, L.,Wenbin, S.,Juan, L....&Teng, L..(2017).The value of postoperative adjuvant therapy for pT2-3 esophageal cancer treated by radical resection.RADIOTHERAPY AND ONCOLOGY,123,
MLA：
Zhu, S.,et al."The value of postoperative adjuvant therapy for pT2-3 esophageal cancer treated by radical resection".RADIOTHERAPY AND ONCOLOGY 123.(2017):S358-S358
医学